US Patent 9169325 Antibodies that bind human CD27 and uses thereof
Patent 9169325 was granted and assigned to Celldex Therapeutics on October, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 24 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+219 characters)
Article
Patent abstract
Isolated monoclonal antibodies which bind to human CD27 and related antibody-based compositions and molecules are disclosed. Also disclosed are therapeutic and diagnostic methods for using the antibodies.
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09169325 Antibodies that bind human CD27 and uses thereof US Patent 9169325 Antibodies that bind human CD27 and uses thereof
Infobox
Patent Number
091693250
Patent Number
91693250
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
091693250
Date of Patent
October 27, 2015
0Patent Application Number
130862860
Date Filed
April 13, 2011
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09169325 Antibodies that bind human CD27 and uses thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09169325
Date of patent
October 27, 2015
Patent application number
13086286
Date Filed
April 13, 2011
Patent primary examiner
Find more entities like US Patent 9169325 Antibodies that bind human CD27 and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
